Validity and test-retest reliability of a disability questionnaire for essential tremor

Movement Disorders

Volumn 15, Issue 3, 2000, Pages 516-523

  Louis, Elan D ^a,b,c   Barnes, Livia F ^a   Wendt, Kristin J ^a   Albert, Steven M ^a,b   Pullman, Seth L ^b   Yu, Qiping ^b   Schneier, Franklin R ^b  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Neurological Institute ^*  (United States)

^c NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Disability; Essential tremor; Questionnaire; Reliability; Validity

Indexed keywords

AGED; ARTICLE; COMPUTER ANALYSIS; DISABILITY; DISEASE SEVERITY; ESSENTIAL TREMOR; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MOTOR PERFORMANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; TREATMENT OUTCOME; VALIDATION PROCESS; VIDEOTAPE;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; ESSENTIAL TREMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR SKILLS; REPRODUCIBILITY OF RESULTS;

EID: 0034126377     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200005)15:3<516::AID-MDS1015>3.0.CO;2-J     Document Type: Article

References (47)

1. Koller WC, Rubino F, Gupta S. Pharmacologic probe with progabide of GABA mechanisms in essential tremor. Arch Neurol 1987; 44:905-906.
2. Sasso E, Perucca E, Fava R, Calzetti S. Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis. Clin Neuropharmacol 1990;13:67-76.
3. Calzetti S, Sasso E, Negrotti A, Baratti M, Fava R. Effect of propranolol in head tremor: quantitative study following single-dose and sustained drug administration. Clin Neuropharmacol 1992;15:470-476.
4. Busenbark K, Pahwa R, Hubble J, Hoptensperger K, Koller W, Pogrebra K. Double-blind controlled study of methazolamide in the treatment of essential tremor. Neurology 1993;43:1045-1047.
5. Ohye C, Shibazaki T, Hirato M, Inoue H, Andou Y, Gamma thalamotomy for parkinsonian and other kinds of tremor. Stereotact Funct Neurosurg 1996;66(suppl 1):333-342.
6. Yoshii F, Shinohara Y, Takeoka T, Kitagawa Y, Akiyama K, Yazaki K. Treatment of essential and parkinsonian tremor with nipradilol. Intern Med 1996;35:861-865.
7. Koller W, Pahwa R, Busenbark K, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 1997;42:292-299.
8. Factor SA, Friedman JH. The emerging role of clozapine in the treatment of movement disorders. Mov Disord 1997;12:483-496.
9. Duff J, Sime E. Surgical interventions in the treatment of Parkinson's disease (PD) and essential tremor (ET): medial pallidotomy in PD and chronic deep brain stimulation (DBS) in PD and ET. Axone 1997;18:85-89.
10. Benabid AL, Benazzouz A, Hoffmann D, Limousin P, Krack P, Pollak P. Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord 1998;13(suppl 3):119-125.
11. Modugno N, Priori A, Berardelli A, Vacca L, Mercuri B, Manfredi M. Botulinum toxin restores presynaptic inhibition of group Ia afferents in patients with essential tremor. Muscle Nerve 1998;21: 1701-1705.
12. Pahwa R, Lyons K, Hubble JP, et al. Double-blind controlled trial of gabapentin in essential tremor. Mov Disord 1998;13:465-467.
13. Ondo W, Jankovic J, Schwartz K, Almaguer M, Simpson RK. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology 1998;51:1063-1069.
14. Limousin P, Speelman JD, Gielen F, Janssens M. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry 1999;66:289-296.
15. Gironell A, Kulisevsky J, Barbanoj M, Lopez-Villegas D, Hernandez G, Pascual-Sedano B. A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol 1999;56:475-480.
16. Bain PG, Findley LJ, Atchison P, et al. Assessing tremor severity. J Neurol Neurosurg Psychiatry 1993;56:868-873.
17. Critchley M. Observations on essential (heredofamilial tremor). Brain 1949;72:113-139.
18. Larsson T, Sjogren T. Essential tremor: a clinical and genetic population study. Acta Psychiatrica Et Neurologica Scandinavica 1960:36(suppl 144):1-176.
19. Hornabrook RW, Nagurney JT. Essential tremor in Papau New Guinea. Brain 1976;99:659-672.
20. Louis ED, Ford B, Wendt KJ, Cameron G. Clinical characteristics of essential tremor: data from a community-based cohort. Mov Disord 1998;13:803-808.
21. Louis ED, Ottman RA, Ford B, et al. The Washington Heights Essential Tremor Study: methodologic issues in essential-tremor research. Neuroepidemiology 1997;16:124-133.
22. Louis ED, Ford B, Lee H, Andrews H. Does a screening questionnaire for essential tremor agree with the physicians' examination? Neurology 1998;50:1351-1357.
23. Louis ED, Ford B, Bismuth B. Reliability between two observers using a protocol for diagnosing essential tremor. Mov Disord 1998; 13:287-293.
24. Wendt KJ, Albert S, Schneier F, Louis ED. The Columbia University Assessment of Disability in Essential Tremor (CADET): methodologic issues in essential tremor research. Journal of Parkinsonism and Related Disorders 2000;6:17-23.
25. Louis ED, Wendt KJ, Albert SM, Pullman SL, Yu Q, Andrews H. Validity of a performance-based test of function in essential tremor. Arch Neurol 1999;56:841-846.
26. Koller WC, Busenbark KL. Essential tremor. In: Watts RL, Koller WC, eds. Movement Disorders. Neurological Principles and Practice. New York, NY: McGraw-Hill, 1997:365-385.
27. Fahn S, Tolosa E, Marin C. Clinical rating scale for tremor: In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. Baltimore, MD: Williams and Wilkins, 1993:271-280.
28. Lyons KE, Pahwa R, Busenbark KL, Troster AI, Wilkinson S, Koller WC. Improvements in daily functioning after deep brain stimulation of the thalamus for intractable tremor. Mov Disord 1998;13:690-692.
29. Louis ED, Wendt KJ, Pullman SL, Ford B. Is essential tremor symmetric? Observational data from a community-based study of essential tremor. Arch Neurol 1998;55:1553-1559.
30. Pullman SL, Elibol B, Fahn S. Modulation of parkinsonian tremor by radial nerve palsy. Neurology 1994;44:1861-1864.
31. Trosch RL, Pullman SL. Botulinum toxin A in the treatment of hand tremors. Mov Disord 1994;9:601-609.
32. Louis ED, Marder K, Cote L, et al. Prevalence of a history of shaking in persons 65 years and older: diagnostic and functional consequences. Mov Disord 1996;11:63-69.
33. Spector WD. Measuring functioning in daily activities for persons with dementia. Alzheimer Dis Assoc Disord 1997;11(suppl 6):81-90.
34. Ward MM. Rheumatology visit frequency and changes in functional disability and pain in patients with rheumatoid arthritis. J Rheumatol 1997;24:35-42.
35. Gallo JJ, Rabins PV, Lyketsos CG, Tien AY, Anthony JC. Depression without sadness: functional outcomes of nondysphoric depression in later life. J Am Geriatr Soc 1997;45:570-578.
36. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Gertiatr Soc 1968;16:622-626.
37. Stern Y, Sano M, Paulson J, Mayeux R. Modified mini-mental state examination: validity and reliability (Abstract). Neurology 1987;37(suppl 1):179.
38. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55.
39. Spielberger CD, Gorsuch RL, Lushene RE. State-Trait Anxiety Inventory: Palo Alto, CA: Consulting Psychologists Press, 1970.
40. Katz SC, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914-919.
41. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
42. First M, Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM IV - Patient Edition (SCID-P). Washington DC: American Psychiatric Press, 1995.
43. Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. New York, NY: John Wiley & Sons, 1991:87-97.
44. Fleiss JL. Statistical Methods for Rules and Proportions. New York, NY: John Wiley & Sons, 1981:222-225.
45. Fleiss JL. Measuring nominal scale agreement among raters. Psychol Bull 1979;86:974-977.
46. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
47. Thompson WD, Walter SD. A reappraisal of the kappa coefficient. J Clin Epidemiol 1988;41:949-958.